Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome — Stella

Home/Neonatal Opioid Withdrawal Syndrome/MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

View on ClinicalTrials.gov

Recruiting

Back to Neonatal Opioid Withdrawal Syndrome trials

MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

Trial locations(1 site)

United States

Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania

Key details

Sponsor

Milton S. Hershey Medical Center

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~50 participants

Started

January 2020

Primary completion

December 2026

Age range

1 Day – 5 Days

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.